These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 27639498)

  • 1. Molecular biomarkers in acute myeloid leukemia.
    Prada-Arismendy J; Arroyave JC; Röthlisberger S
    Blood Rev; 2017 Jan; 31(1):63-76. PubMed ID: 27639498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
    Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
    Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.
    Ryotokuji T; Yamaguchi H; Ueki T; Usuki K; Kurosawa S; Kobayashi Y; Kawata E; Tajika K; Gomi S; Kanda J; Kobayashi A; Omori I; Marumo A; Fujiwara Y; Yui S; Terada K; Fukunaga K; Hirakawa T; Arai K; Kitano T; Kosaka F; Tamai H; Nakayama K; Wakita S; Fukuda T; Inokuchi K
    Haematologica; 2016 Sep; 101(9):1074-81. PubMed ID: 27247325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.
    Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L
    J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications.
    Yang X; Wong MPM; Ng RK
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia.
    Weng H; Lal K; Yang FF; Chen J
    Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in AML.
    Melnick AM
    Best Pract Res Clin Haematol; 2010 Dec; 23(4):463-8. PubMed ID: 21130408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New prognostic markers in acute myeloid leukemia: perspective from the clinic.
    Foran JM
    Hematology Am Soc Hematol Educ Program; 2010; 2010():47-55. PubMed ID: 21239770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing DNA methylation-based prognostic biomarkers of acute myeloid leukemia.
    Gao C; Zhuang J; Zhou C; Liu L; Liu C; Li H; Zhao M; Liu G; Sun C
    J Cell Biochem; 2018 Dec; 119(12):10041-10050. PubMed ID: 30171717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
    Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
    Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia.
    Alvarez S; Suela J; Valencia A; Fernández A; Wunderlich M; Agirre X; Prósper F; Martín-Subero JI; Maiques A; Acquadro F; Rodriguez Perales S; Calasanz MJ; Roman-Gómez J; Siebert R; Mulloy JC; Cervera J; Sanz MA; Esteller M; Cigudosa JC
    PLoS One; 2010 Aug; 5(8):e12197. PubMed ID: 20808941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of molecular markers in acute myeloid leukemia.
    Kayser S; Levis MJ
    Eur J Haematol; 2019 Jan; 102(1):20-35. PubMed ID: 30203623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
    Hájková H; Marková J; Haškovec C; Sárová I; Fuchs O; Kostečka A; Cetkovský P; Michalová K; Schwarz J
    Leuk Res; 2012 Sep; 36(9):1128-33. PubMed ID: 22749068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers in acute myeloid leukaemia.
    Kühnl A; Grimwade D
    Int J Hematol; 2012 Aug; 96(2):153-63. PubMed ID: 22791509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
    Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
    Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy-number analysis identified new prognostic marker in acute myeloid leukemia.
    Nibourel O; Guihard S; Roumier C; Pottier N; Terre C; Paquet A; Peyrouze P; Geffroy S; Quentin S; Alberdi A; Abdelali RB; Renneville A; Demay C; Celli-Lebras K; Barbry P; Quesnel B; Castaigne S; Dombret H; Soulier J; Preudhomme C; Cheok MH
    Leukemia; 2017 Mar; 31(3):555-564. PubMed ID: 27686867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The increasing genomic complexity of acute myeloid leukemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2014; 27(3-4):209-13. PubMed ID: 25455268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy.
    Hiller JK; Schmoor C; Gaidzik VI; Schmidt-Salzmann C; Yalcin A; Abdelkarim M; Blagitko-Dorfs N; Döhner K; Bullinger L; Duyster J; Lübbert M; Hackanson B
    Ann Hematol; 2017 Apr; 96(4):559-565. PubMed ID: 28058491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.
    Bret C; Viziteu E; Kassambara A; Moreaux J
    Expert Rev Hematol; 2016; 9(4):351-60. PubMed ID: 26761438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.